bioAffinity Technologies Q3 EPS $(5.89) Up From $(71.05) YoY, Sales $1.070M Down From $1.446M YoY

bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(5.89) per share. This is a 91.71 percent increase over losses of $(71.05) per share from the same period last year. The company reported $1.070 million in sales this quarter. This is a 26.00 percent decrease over sales of $1.446 million the same period last year.